Early Prostate Cancer Screenings: A Veteran's Call to Action
November 29, 2024 - 16:00
Former Army Green Beret Jeff Bosley has a powerful message for men as he reflects on his journey with prostate cancer, a diagnosis he received in his mid-40s—a time when such cases are quite uncommon. Grateful for the support and care he received, Bosley is now dedicated to raising awareness about the importance of early screenings for prostate cancer.
In his advocacy, Bosley encourages men to overcome the stigma surrounding prostate health and to prioritize regular check-ups. He emphasizes that early detection can significantly improve treatment outcomes and save lives. Many men shy away from discussing prostate health due to embarrassment or misconceptions, but Bosley believes that open conversations can lead to better health practices.
As Men's Health Month unfolds, Bosley's story serves as a reminder that taking proactive steps toward health can make a difference. He urges men everywhere to be vigilant about their health and to seek the necessary screenings without delay.
MORE NEWS
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...